A clinical trial to test the safety and efficacy of dose escalation of non-alpha IL-2 mutein. A product obtained at the Center for Molecular Immunology. It is being carried out at the Hermanos Ameijeiras Clinical Surgical Hospital in Havana.
According to Oncology specialist Vilma Fleites. This drug is applied to patients with advanced solid tumors in progression. Who have been subjected to other treatments.
The research has completed the first phase and is in a second stage of studies. With positive results in terms of the effectiveness of anti-tumor therapy, she said.
She stressed that these trials are a fundamental pillar for clinical oncologists. As new care protocols are discovered and applied that allow the management of clinical oncology in a clinical way. A palliative care of patients, without other options for oncological therapies, she said.
Today, in this service of that institution, several clinical trials are being carried out. In the effort to find new effective drugs against various variants of cancer. Which is the second cause of death in Cuba.
With information from Cuban News Agency
Translated by Aliani Rojas Fernández
Latest posts by Radio Angulo (see all)
- Campaign Against Arboviruses Intensifies in Moa - 13 de December de 2025
- The 11th Plenum of the Central Committee of the PCC Convenes - 13 de December de 2025
- ANPP readjusts its session period amid complex national scenario - 13 de December de 2025